Effect of Simvastatin on Ischemic Signs and Symptoms in the Scandinavian Simvastatin Survival Study (4S) Terje R. Pedersen...
Background <ul><li>This analysis examines the effect of lipid intervention with simvastatin on noncoronary ischemic sympto...
Patients With a New or Worsening Angina Pectoris, Intermittent Claudication, or Bruits The American Journal of Cardiology ...
Kaplan-Meier Curve for Patients in 4S with New or Worsening Intermittent Claudication The American Journal of Cardiology V...
Kaplan-Meier Curve for Patients in 4S with New or Worsening Carotid Bruit The American Journal of Cardiology Vol. 81 Febru...
Kaplan-Meier Curve for Patients in 4S with New or Worsening Angina Pectoris The American Journal of Cardiology Vol. 81 Feb...
Kaplan-Meier Curve for Patients in 4S with New or Worsening Cerebrovascular Events The American Journal of Cardiology Vol....
Patients in 4S With Reduced Risk for Ischemic Signs and Symptoms The American Journal of Cardiology Vol. 81 February 1, 19...
Conclusion <ul><li>“ This analysis provides evidence that effective cholesterol lowering with simvastatin 20 to 40 mg/day ...
Upcoming SlideShare
Loading in...5
×

Stroke

368

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
368
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Stroke

  1. 1. Effect of Simvastatin on Ischemic Signs and Symptoms in the Scandinavian Simvastatin Survival Study (4S) Terje R. Pedersen, MD, John Kjekshus, MD, Kalevi Pyorala, MD, Anders G. Olsson, MD, Thomas J. Cook, MS, Thomas A. Musliner, MD, Jonathan A. Tobert, MD, PhD, and Torben Haghfelt, MD The American Journal of Cardiology Vol. 81 February 1, 1998
  2. 2. Background <ul><li>This analysis examines the effect of lipid intervention with simvastatin on noncoronary ischemic symptoms and signs during a median follow-up of 5.4 years. </li></ul><ul><li>This analysis also provides new information on the effect of simvastatin on angina pectoris. </li></ul>The American Journal of Cardiology Vol. 81 February 1, 1998
  3. 3. Patients With a New or Worsening Angina Pectoris, Intermittent Claudication, or Bruits The American Journal of Cardiology Vol. 81 February 1, 1998
  4. 4. Kaplan-Meier Curve for Patients in 4S with New or Worsening Intermittent Claudication The American Journal of Cardiology Vol. 81 February 1, 1998 38% risk reduction p=0.008
  5. 5. Kaplan-Meier Curve for Patients in 4S with New or Worsening Carotid Bruit The American Journal of Cardiology Vol. 81 February 1, 1998 48% risk reduction p=0.009
  6. 6. Kaplan-Meier Curve for Patients in 4S with New or Worsening Angina Pectoris The American Journal of Cardiology Vol. 81 February 1, 1998 26% risk reduction p<0.0001
  7. 7. Kaplan-Meier Curve for Patients in 4S with New or Worsening Cerebrovascular Events The American Journal of Cardiology Vol. 81 February 1, 1998 28% risk reduction p=0.033
  8. 8. Patients in 4S With Reduced Risk for Ischemic Signs and Symptoms The American Journal of Cardiology Vol. 81 February 1, 1998 Angina pectoris Intermittent claudication   1 bruit Carotid bruit Femoral bruit P<0.0001 P=0.008 P=0.025 P=0.009 P=0.59 Stroke & TIA P=0.033
  9. 9. Conclusion <ul><li>“ This analysis provides evidence that effective cholesterol lowering with simvastatin 20 to 40 mg/day will retard progression of atherosclerosis in the arterial vasculature, not limited to the coronary circulation, resulting in less ischemic signs and symptoms.” </li></ul>The American Journal of Cardiology Vol. 81 February 1, 1998
  1. Gostou de algum slide específico?

    Recortar slides é uma maneira fácil de colecionar informações para acessar mais tarde.

×